Log In
BCIQ
Print this Print this
 

Kiklin, bixalomer (AMG 223, ASP1585)

Also known as: formerly ILY101

  Manage Alerts
Collapse Summary General Information
Company Amgen Inc.
DescriptionMetal-free, non-absorbed polymeric phosphate-binding agent
Molecular Target Phosphate
Mechanism of ActionPhosphate binder
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHyperphosphatemia
Indication DetailsTreat hyperphosphatemia in patients with chronic kidney disease (CKD) not on dialysis; Treat hyperphosphatemia in patients with chronic kidney disease (CKD) on hemodialysis
Regulatory Designation
PartnerAstellas Pharma Inc.;
Sanwa Kagaku Kenkyusho Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

02/27/2012

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today